Trial · NCT02224664
Results by group244
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 244
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | L-Dopa | AEs | 9 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 5 mg + L-Dopa | AEs | 9 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 15 mg + L-Dopa | AEs | 7 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | AEs | 5 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 25 mg + L-Dopa | AEs | 15 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | L-Dopa | SAEs | 0 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 5 mg + L-Dopa | SAEs | 0 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 15 mg + L-Dopa | SAEs | 0 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | SAEs | 0 | participants | |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | PF-06649751 25 mg + L-Dopa | SAEs | 1 | participants | |
| Number of Participants With Laboratory Test Abnormalities | L-Dopa | 17 | participants | ||
| Number of Participants With Laboratory Test Abnormalities | PF-06649751 5 mg + L-Dopa | 8 | participants | ||
| Number of Participants With Laboratory Test Abnormalities | PF-06649751 15 mg + L-Dopa | 8 | participants | ||
| Number of Participants With Laboratory Test Abnormalities | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | 5 | participants | ||
| Number of Participants With Laboratory Test Abnormalities | PF-06649751 25 mg + L-Dopa | 11 | participants | ||
| Number of Participants With Vital Sign Abnormalities | L-Dopa | Supine SBP: <90 mmHg (n =50, 9, 11, 6, 19) | 2 | participants | |
| Number of Participants With Vital Sign Abnormalities | PF-06649751 5 mg + L-Dopa | Supine SBP: <90 mmHg (n =50, 9, 11, 6, 19) | 1 | participants | |
| Number of Participants With Vital Sign Abnormalities | PF-06649751 15 mg + L-Dopa | Supine SBP: <90 mmHg (n =50, 9, 11, 6, 19) | 1 | participants | |
| Number of Participants With Vital Sign Abnormalities | PF-06649751 15 mg + L-Dopa: L-dopa Induced Dyskinesia (LID) | Supine SBP: <90 mmHg (n =50, 9, 11, 6, 19) | 1 | participants | |
| Number of Participants With Vital Sign Abnormalities | PF-06649751 25 mg + L-Dopa | Supine SBP: <90 mmHg (n =50, 9, 11, 6, 19) | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02224664/results